Skip to main content
SpringerLink
Log in

Pretransplant mogamulizumab against ATLL might increase the risk of acute GVHD and non-relapse mortality

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Matsuoka M, Jeang KT . Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 2007; 7: 270–280.

    Article  CAS  Google Scholar 

  2. Tsukasaki K, Utsunomiya A, Fukuda H, Shibata T, Fukushima T, Takatsuka Y et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol 2007; 25: 5458–5464.

    Article  CAS  Google Scholar 

  3. Fukushima T, Nomura S, Shimoyama M, Shibata T, Imaizumi Y, Moriuchi Y et al. Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A). Br J Haematol 2014; 166: 739–748.

    Article  Google Scholar 

  4. Yamamoto K, Utsunomiya A, Tobinai K, Tsukasaki K, Uike N, Uozumi K et al. Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. J Clin Oncol 2010; 28: 1591–1598.

    Article  CAS  Google Scholar 

  5. Ishida T, Joh T, Uike N, Yamamoto K, Utsunomiya A, Yoshida S et al. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. J Clin Oncol 2012; 30: 837–842.

    Article  CAS  Google Scholar 

  6. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M . Immunologic self-tolerance maintained by activated T cells expressing 11-2 receptor a-chains (CD25). J Immunol 1995; 155: 1151–1164.

    CAS  Google Scholar 

  7. Michael M, Shimoni A, Nagler A . Regulatory T cells in allogeneic stem cell transplantation. Clin Dev Immunol 2013; 2013: 608951.

    Article  Google Scholar 

  8. Cohen JL, Trenado A, Vasey D, Klatzmann D, Salomon BL . CD4(+)CD25(+) immunoregulatory T cells: new therapeutics for graft-versus-host disease. J Exp Med 2002; 196: 401–406.

    Article  CAS  Google Scholar 

  9. Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S . Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 2002; 196: 389–399.

    Article  CAS  Google Scholar 

  10. Taylor PA, Lees CJ, Blazar BR . The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 2002; 99: 3493–3499.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This research was supported by the Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development, AMED. We thank the medical, nursing, data-processing, laboratory and clinical staff at our center for their important contributions to this study and their dedicated care of the patients.

Author contributions

YI and SF participated in research design, data analysis and writing of the paper; RT and TF participated in research design and writing of the paper; and all authors approved the submission of this study.

Author information

Authors and Affiliations

  1. Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan

    Y Inoue, S Fuji & T Fukuda

  2. Juntendo University Graduate School of Medicine, Tokyo, Japan

    Y Inoue & S Fuji

  3. Blood Transfusion Division, National Cancer Center Hospital, Tokyo, Japan

    R Tanosaki

Authors
  1. Y Inoue
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Fuji
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R Tanosaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T Fukuda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S Fuji.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Inoue, Y., Fuji, S., Tanosaki, R. et al. Pretransplant mogamulizumab against ATLL might increase the risk of acute GVHD and non-relapse mortality. Bone Marrow Transplant 51, 725–727 (2016). https://doi.org/10.1038/bmt.2015.315

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2015.315

  • Springer Nature Limited

This article is cited by

Search

Navigation